Latest Insights on EXPR
The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]Mexico’s Sword of Damocles
June 10, 2019 Great Stuff
The U.S. and Mexico reached an agreement on trade and immigration this weekend. So, it’s time to celebrate. Crisis averted! Or is it? The promised 5% tariff on Mexican goods hasn’t been completely eradicated. It’s just been “indefinitely suspended.” In other words, President Trump could bring it back at any moment if he decides that […]
Why Africa Is the Greatest Investment Opportunity of the 21st Century May 8, 2019 Global Economy, Investment Opportunities, Winning Investor Daily
What if you could invest in companies targeting the retail sector in the fastest-growing consumer market in the world?
Why Uber Won’t Be the Next Amazon Stock May 1, 2019 Investment Opportunities, Technology, Winning Investor Daily
The spinmeisters at Uber want you to associate the company with Amazon so you will buy it at its IPO. I don’t believe that for one second, and neither should you.
Get Ready to Trade Medicare for All’s Volatility April 24, 2019 Government & Politics, U.S. Economy, Winning Investor Daily
I’ve experienced the absurdity of American health care enough to know that the possibility of a “Medicare for All” program is real. That calls for some seriously strategic investing.






